These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 33234509

  • 1. Loss of Fbxw7 Impairs Development of and Induces Heterogeneous Tumor Formation in the Mouse Mammary Gland.
    Onoyama I, Nakayama S, Shimizu H, Nakayama KI.
    Cancer Res; 2020 Dec 15; 80(24):5515-5530. PubMed ID: 33234509
    [Abstract] [Full Text] [Related]

  • 2. Loss of Fbxw7 triggers mammary tumorigenesis associated with E2F/c-Myc activation and Trp53 mutation.
    Meyer AE, Furumo Q, Stelloh C, Minella AC, Rao S.
    Neoplasia; 2020 Nov 15; 22(11):644-658. PubMed ID: 33070870
    [Abstract] [Full Text] [Related]

  • 3. Fbxw7 is a driver of uterine carcinosarcoma by promoting epithelial-mesenchymal transition.
    Cuevas IC, Sahoo SS, Kumar A, Zhang H, Westcott J, Aguilar M, Cortez JD, Sullivan SA, Xing C, Hayes DN, Brekken RA, Bae-Jump VL, Castrillon DH.
    Proc Natl Acad Sci U S A; 2019 Dec 17; 116(51):25880-25890. PubMed ID: 31772025
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Whole-exome DNA sequence analysis of Brca2- and Trp53-deficient mouse mammary gland tumours.
    Francis JC, Melchor L, Campbell J, Kendrick H, Wei W, Armisen-Garrido J, Assiotis I, Chen L, Kozarewa I, Fenwick K, Swain A, Smalley MJ, Lord CJ, Ashworth A.
    J Pathol; 2015 Jun 17; 236(2):186-200. PubMed ID: 25692405
    [Abstract] [Full Text] [Related]

  • 7. Fbxw7 regulates lipid metabolism and cell fate decisions in the mouse liver.
    Onoyama I, Suzuki A, Matsumoto A, Tomita K, Katagiri H, Oike Y, Nakayama K, Nakayama KI.
    J Clin Invest; 2011 Jan 17; 121(1):342-54. PubMed ID: 21123947
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway.
    Mu Y, Zou H, Chen B, Fan Y, Luo S.
    Biomed Pharmacother; 2017 Jun 17; 90():548-554. PubMed ID: 28407575
    [Abstract] [Full Text] [Related]

  • 10. Efficient BLG-Cre mediated gene deletion in the mammary gland.
    Selbert S, Bentley DJ, Melton DW, Rannie D, Lourenço P, Watson CJ, Clarke AR.
    Transgenic Res; 1998 Sep 17; 7(5):387-96. PubMed ID: 9859227
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. SCF(FBXW7)-mediated degradation of p53 promotes cell recovery after UV-induced DNA damage.
    Galindo-Moreno M, Giráldez S, Limón-Mortés MC, Belmonte-Fernández A, Reed SI, Sáez C, Japón MÁ, Tortolero M, Romero F.
    FASEB J; 2019 Oct 17; 33(10):11420-11430. PubMed ID: 31337255
    [Abstract] [Full Text] [Related]

  • 13. Overexpression and forced activation of stat5 in mammary gland of transgenic mice promotes cellular proliferation, enhances differentiation, and delays postlactational apoptosis.
    Iavnilovitch E, Groner B, Barash I.
    Mol Cancer Res; 2002 Nov 17; 1(1):32-47. PubMed ID: 12496367
    [Abstract] [Full Text] [Related]

  • 14. Alpha-6 integrin deletion delays the formation of Brca1/p53-deficient basal-like breast tumors by restricting luminal progenitor cell expansion.
    Faraldo MM, Romagnoli M, Wallon L, Dubus P, Deugnier MA, Fre S.
    Breast Cancer Res; 2024 Jun 04; 26(1):91. PubMed ID: 38835038
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. R-spondin3 Is Associated with Basal-Progenitor Behavior in Normal and Tumor Mammary Cells.
    Tocci JM, Felcher CM, García Solá ME, Goddio MV, Zimberlin MN, Rubinstein N, Srebrow A, Coso OA, Abba MC, Meiss RP, Kordon EC.
    Cancer Res; 2018 Aug 15; 78(16):4497-4511. PubMed ID: 29748375
    [Abstract] [Full Text] [Related]

  • 17. FBXW7 deletion contributes to lung tumor development and confers resistance to gefitinib therapy.
    Xiao Y, Yin C, Wang Y, Lv H, Wang W, Huang Y, Perez-Losada J, Snijders AM, Mao JH, Zhang P.
    Mol Oncol; 2018 Jun 15; 12(6):883-895. PubMed ID: 29633504
    [Abstract] [Full Text] [Related]

  • 18. Transcription factor AP-2gamma stimulates proliferation and apoptosis and impairs differentiation in a transgenic model.
    Jäger R, Werling U, Rimpf S, Jacob A, Schorle H.
    Mol Cancer Res; 2003 Oct 15; 1(12):921-9. PubMed ID: 14573793
    [Abstract] [Full Text] [Related]

  • 19. Mnt-deficient mammary glands exhibit impaired involution and tumors with characteristics of myc overexpression.
    Toyo-oka K, Bowen TJ, Hirotsune S, Li Z, Jain S, Ota S, Escoubet-Lozach L, Garcia-Bassets I, Lozach J, Rosenfeld MG, Glass CK, Eisenman R, Ren B, Hurlin P, Wynshaw-Boris A.
    Cancer Res; 2006 Jun 01; 66(11):5565-73. PubMed ID: 16740691
    [Abstract] [Full Text] [Related]

  • 20. Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer.
    Gastaldi S, Sassi F, Accornero P, Torti D, Galimi F, Migliardi G, Molyneux G, Perera T, Comoglio PM, Boccaccio C, Smalley MJ, Bertotti A, Trusolino L.
    Oncogene; 2013 Mar 14; 32(11):1428-40. PubMed ID: 22562252
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.